After the women's health initiative: Decision making and trust of women taking hormone therapy

Women's Health Issues

Volumn 15, Issue 4, 2005, Pages 187-195

  Schonberg, Mara A ^a   Davis, Roger B ^a   Wee, Christina C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; HORMONE; NEW DRUG;

ACADEMIC ACHIEVEMENT; ADULT; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH; HEALTH BEHAVIOR; HEALTH SURVEY; HEART DISEASE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PATIENT; PREVALENCE; PRIMARY MEDICAL CARE; PROPHYLAXIS; RACE DIFFERENCE; RANDOMIZATION; REVIEW; TELEPHONE; TREATMENT WITHDRAWAL; TRUST;

EID: 22744439470     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2005.03.003     Document Type: Article

References (47)

1. R.N. Anderson, B.L. Smith Death leading causes for 2001 National Vital Statistics Report 52 9 2003 1 86
2. D.E. Arnold, R.P. Holm The quantity and quality of medical information available to the public South Dakota Journal of Medicine 49 2 1996 69 74
3. J. Benbassat, D. Pilpel, M. Tidhar Patients' preferences for participation in clinical decision-making a review of published surveys Behavioral Medicine 24 2 1998 81 88
4. R.J. Blendon, H. Taylor Views on health care public opinion in three nations Health Affairs (Millwood) 8 1989 149 157
5. J.E. Blumel, C. Castelo-Branco, P.A. Chedraui, L. Binfa, B. Dowlani, M.S. Gomez, S. Sarra Patients and clinicians' attitudes after the women's health initiative study Menopause 11 1 2004 57 61
6. L.E. Boulware, L.A. Cooper, L.E. Ratner, T.A. Laveist, N.R. Powe Race and trust in the health care system Public Health Reports 118 2003 358 365
7. E.S. Breslau, W.W. Davis, L. Doner, E.J. Eisner, N.R. Goodman, H.I. Meissner The hormone therapy dilemma women respond Journal of the American Medical Women's Association 58 1 2003 33 43
8. R. Brull, W.A. Ghali, H. Quan Missed opportunities for prevention in general internal medicine Canadian Medical Association Journal 160 8 1999 1137 1140
9. W. Burke, A.H. Olsen, L.E. Pinsky, S.E. Reynolds, N.A. Press Misleading presentation of breast cancer in popular magazines Effective Clinical Practice 4 2 2001 58 64
10. C. Clinkingbeard, B.A. Minton, J. Davis, K. McDermott Women's knowledge about menopause, hormone replacement therapy (HRT), and interactions with healthcare providers an exploratory study Journal of Women's Health and Gender Based Medicine 8 8 1999 1097 1102
11. G. Corbie-Smith, S.B. Thomas, D.M. St. George Distrust, race, and research Archives of Internal Medicine 162 2002 2458 2463
12. M.P. Doescher, B.G. Saver, P. Franks, K. Fiscella Racial and ethnic disparities in perceptions of physician style and trust Archives of Family Medicine 9 2000 1156 1161
13. J. Ende, L. Kazis, A. Ash, M.A. Moskowitz Measuring patients' desire for autonomy decision making and information-seeking preferences among medical patients Journal of General Internal Medicine 4 4 1989 360 361
14. B. Ettinger, D. Grady, A.N. Tosteson, A. Pressman, J.L. Macer Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy Obstetrics and Gynecology 102 6 2003 1225 1232
15. L. Glickman, M. Hubbard, T. Liveright, J.A. Valciukas Fall-off in reporting life events effects of life change, desirability, and anticipation Behavioral Medicine 16 1 1990 31 38
16. E. Goodman (April 17) To swallow or not to swallow that is the new vitamin question 1994 Boston Globe, A27.
17. S.M. Green Estrogens S.M. Green Tarascon pocket pharmacopoeia 2002 Tarascon Publishing Loma Linda, CA 82 86
18. J.S. Haas, C.P. Kaplan, E.P. Gerstenberger, K. Kerlikowske Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results Annals of Internal Medicine 140 3 2004 184 189
19. M.A. Hall, F. Camacho, E. Dugan, R. Balkrishnan Trust in the medical profession conceptual and measurement issues HSR Health Services Research 37 5 2002 1419 1439
20. M.A. Hall, E. Dugan, B. Zheng, A. Mishra Trust in physicians and medical institutions what is it, can it be measured, and does it matter? Milbank Quarterly 79 4 2001 613 639
21. A.L. Hersh, M.L. Stefanick, R.S. Stafford National use of postmenopausal hormone therapy; annual trends and response to recent evidence Journal of the American Medical Association 291 1 2004 47 53
22. B.B. Johnson, P. Slovic Presenting uncertainty in health risk assessment initial studies of its effects on risk perception and trust Risk Analysis 15 4 1995 485 494
23. B. Lawton, S. Rose, D. McLeod, A. Dowell Changes in use of hormone replacement therapy after the report from the Women's Health Initiative cross sectional survey of users British Medical Journal 327 2003 845 846
24. C. Marino, K.K. Gerlach An analysis of breast cancer coverage in selected women's magazines, 1987-1995 American Journal of Health Promotion 13 3 1999 163 170
25. K.A. Martin, H.N. Rosen, R.L. Barbieri Hormone preparations for estrogen replacement therapy 2003 Available: http://www.uptodateonline.com. Accessed April 22, 2003.
26. S. Millon-Underwood, E. Sanders, M. Davis Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans Cancer Nursing 16 1 1993 25 33
27. L. Mosca, W.K. Jones, K.B. King, P. Ouyang, R.F. Redberg, M.N. Hill Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States Archives of Family Medicine 9 6 2000 506 515
28. National Institutes of Health NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk, lack of overall benefit. July 9 2002 Available: http://www.nhlbi.nih.gov/new/press/02-07-09.htm/. Accessed January 23, 2005.
29. J.M. Neuner, E.P. McCarthy, R.B. Davis, R.S. Phillips Physician counseling on hormone replacement therapy and bone loss do socioeconomic and racial characteristics of women influence counseling? Journal of Women's Health 12 5 2003 495 504
30. North American Menopause Society Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy Menopause 10 1 2003 6 12
31. The Patient-Physician Relationship The impact of managed care on patients' trust in medical care and their physicians JAMA 275 21 1996 1693 1697
32. S.D. Pearson, L.H. Raeke Patients' trust in physicians many theories, few measures, and little data Journal of General Internal Medicine 15 2000 509 513
33. L. Pilote Attitudes of women toward hormone therapy and prevention of heart disease American Heart Journal 129 6 1995 1237 1238
34. N.L. Roberson Clinical trial participation. Viewpoints from racial/ethnic groups Cancer 74 9 Suppl 1994 2687 2691
35. A. Rose, N. Peters, J.A. Shea, K. Armstrong Development and testing of the health care system distrust scale Journal of General Internal Medicine 19 1 2004 57 63
36. R.J. Ruggiero Patient communication and counseling on contraception and hormone replacement therapy American Journal of Managed Care 7 18 Supplement 2001 S580 S585
37. D.G. Safran, D.A. Taira, W.H. Rogers, M. Kosinski, J.E. Ware, A.R. Tarlov Linking primary care performance to outcomes of care The Journal of Family Practice 47 3 1998 213 220
38. B.G. Saver, T.R. Taylor, N.F. Woods, N.G. Stevens Physician policies on the use of preventive hormone therapy American Journal of Preventive Medicine 13 5 1997 358 365
39. D.L. Schneider, E.L. Barrett-Connor, D.J. Morton Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo study Journal of the American Medical Association 277 7 1997 543 547
40. P. Sleight Where are clinical trials going? Society and clinical trials Journal of Internal Medicine 255 2004 151 158
41. U.S. Preventive Services Task Force Postmenopausal hormone replacement therapy for primary prevention of chronic conditions recommendations and rationale Annals of Internal Medicine 137 2002 834 839
42. H.H. Weng, C.M. McBride, H.B. Bosworth, S.C. Grambow, I.C. Siegler, L.A. Bastian Racial differences in physician recommendation of hormone replacement therapy Preventive Medicine 33 2001 668 673
43. Women's Health Initiative Investigators Estrogen plus progestin and the risk of coronary heart disease New England Journal of Medicine 349 6 2003 523 534
44. The Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy the Women's Health Initiative randomized controlled trial Journal of the American Medical Association 291 14 2004 1701 1712
45. Writing Group Cardiovascular disease in women a statement for healthcare professionals from the American Heart Association Circulation 96 1997 2468 2482
46. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women; principal results from the Women's Health Initiative randomized controlled trial Journal of the American Medical Association 288 3 2000 321 333
47. J. Zhang, K.F. Yu What's the relative risk? A method of correcting the odds ration in cohort studies of common outcomes Journal of the American Medical Association 280 19 1998 1690 1691